Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Sep'24
Net Sales
228.25
213.05
160.93
145.30
119.85
167.41
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
228.25
213.05
160.93
145.30
119.85
167.41
0.00
Raw Material Cost
179.73
175.40
118.91
100.44
91.08
125.01
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-6.35
-22.09
-7.35
4.41
-6.66
-1.23
0.00
Employee Cost
7.12
8.86
8.15
8.30
7.63
9.70
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.07
4.65
3.72
3.67
3.64
4.59
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
10.94
17.35
11.16
6.14
7.17
12.09
0.00
Total Expenditure (Excl Depreciation)
195.51
184.17
134.59
122.96
102.86
150.16
0.00
Operating Profit (PBDIT) excl Other Income
32.74
28.88
26.34
22.34
16.99
17.25
0.00
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Operating Profit (PBDIT)
32.74
28.88
26.34
22.34
16.99
17.25
0.00
Interest
8.62
14.49
10.55
7.73
6.53
8.15
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
24.12
14.39
15.79
14.61
10.46
9.10
0.00
Depreciation
3.57
3.15
1.78
1.89
1.42
1.84
0.00
Profit Before Tax
20.55
11.25
14.00
12.71
9.04
7.26
0.00
Tax
7.42
0.47
3.52
3.27
2.27
1.26
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
13.13
10.78
10.48
9.43
6.77
6.00
0.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
13.13
10.78
10.48
9.43
6.77
6.00
0.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
13.13
10.78
10.48
9.43
6.77
6.00
0.00
Equity Capital
5.51
5.47
5.37
4.72
4.72
4.72
4.72
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
7.94
6.57
19.52
19.98
4.78
12.71
0.0
Diluted Earnings per share
7.4
6.07
22.19
19.98
4.78
12.71
0.0
Operating Profit Margin (Excl OI)
14.37%
13.73%
16.47%
15.56%
14.23%
10.43%
0.0%
Gross Profit Margin
10.59%
6.84%
9.87%
10.17%
8.76%
5.5%
0.0%
PAT Margin
5.76%
5.12%
6.55%
6.57%
5.67%
3.63%
0.0%
Public Share Holdings (%)
55.43%
55.83%
56.94%
51.07%
51.07%
51.07%
50.84%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 90.75% vs 53.99% in Jun 2025
Standalone Net Profit
YoY Growth in quarter ended Jun 2026 is 94.53% vs 63.92% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 92.94% vs 61.96% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 32.01% vs 67.01% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Fredun Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
228.25
72.97
155.28
212.80%
Other Operating Income
0.00
0.00
0.00
Total Operating income
228.25
72.97
155.28
212.80%
Raw Material Cost
179.73
40.04
139.69
348.88%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-6.35
-5.45
-0.90
-16.51%
Employee Cost
7.12
11.46
-4.34
-37.87%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
4.07
-0.01
4.08
40,800.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
10.94
5.69
5.25
92.27%
Total Expenditure (Excl Depreciation)
195.51
51.73
143.78
277.94%
Operating Profit (PBDIT) excl Other Income
32.74
21.24
11.50
54.14%
Other Income
0.00
1.54
-1.54
-100.00%
Operating Profit (PBDIT)
32.74
22.78
9.96
43.72%
Interest
8.62
1.67
6.95
416.17%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
24.12
21.11
3.01
14.26%
Depreciation
3.57
6.54
-2.97
-45.41%
Profit Before Tax
20.55
14.58
5.97
40.95%
Tax
7.42
4.30
3.12
72.56%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
13.13
10.28
2.85
27.72%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
13.13
10.28
2.85
27.72%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
13.13
10.28
2.85
27.72%
Equity Capital
5.51
22.25
-16.74
-75.24%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
7.94
4.62
3.32
71.86%
Diluted Earnings per share
7.40
4.62
2.78
60.17%
Operating Profit Margin (Excl OI)
14.37%
29.11%
0.00
-14.74%
Gross Profit Margin
10.59%
28.93%
0.00
-18.34%
PAT Margin
5.76%
14.09%
0.00
-8.33%
Public Share Holdings (%)
55.43%
0.00%
55.43
55.43%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 227.76 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is 8.25% vs 31.56% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 90.75% vs 53.99% in Jun 2025
Quarterly - Standalone Net Profit
Standalone Net Profit 13.17 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is 18.97% vs 5.63% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 94.53% vs 63.92% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.78 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is 12.53% vs 10.59% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 92.94% vs 61.96% in Jun 2025
Quarterly - Interest
Interest 8.62 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is -40.51% vs 37.35% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 32.01% vs 67.01% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.39%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
